| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 518 |
| 1 | ADALIMUMAB | 407 |
| 2 | METHOTREXATE SODIUM | 398 |
| 3 | METHOTREXATE | 361 |
| 4 | TOCILIZUMAB | 235 |
| 5 | INFLIXIMAB | 222 |
| 6 | LEFLUNOMIDE | 209 |
| 7 | ABATACEPT | 198 |
| 8 | HYDROXYCHLOROQUINE | 160 |
| 9 | RITUXIMAB | 155 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 67 | 0.0115 |
| 1 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 2 | METEX | 3 | 0.0079 |
| 3 | DIETHYLPROPION HYDROCHLORIDE | 1 | 0.0078 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 19 | 0.0069 |
| 5 | MINOCYCLINE HYDROCHLORIDE | 40 | 0.0067 |
| 6 | TOLMETIN SODIUM | 1 | 0.0059 |
| 7 | ANAKINRA | 96 | 0.0057 |
| 8 | CANAKINUMAB | 61 | 0.0056 |
| 9 | TRIPROLIDINE HYDROCHLORIDE | 1 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 618 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 357 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 238 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 210 |
| 4 | Antirheumatic Agent [EPC] | 209 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 198 |
| 6 | Corticosteroid [EPC] | 194 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 162 |
| 8 | Aminosalicylate [EPC] | 140 |
| 9 | Vitamin D [EPC] | 120 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 96 | 0.0057 |
| 1 | Antirheumatic Agent [EPC] | 209 | 0.0020 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 238 | 0.0017 |
| 3 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 4 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 198 | 0.0014 |
| 6 | Aminosalicylate [EPC] | 140 | 0.0014 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 357 | 0.0008 |
| 8 | Janus Kinase Inhibitor [EPC] | 119 | 0.0007 |
| 9 | Prostaglandin E1 Analog [EPC] | 12 | 0.0007 |